Reaction profile

The FDA adverse-event record for conjunctival haemorrhage

15 FDA reports name conjunctival haemorrhage, a lower-volume reaction in the CVM extract (VeDDRA 2459). Plate stamps and neighbourhood peers follow.

#2295 of 2,481
by report volume (all reactions)
15
reports citing this reaction
20.0%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Conjunctival haemorrhage has 15 reports now versus 15 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Conjunctival haemorrhage changes

FDA AER · VeDDRA plate

Code 2459 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 15 reports
  • DEATH-HOT 20.0%
  • BOTTOM-DECILE #2295/2481
  • PHOTO-FINISH Abomasal ulcer
  • SPECIES-DOG Dog · 13
  • DRUG-LEAD Maropitant Citrate · 3
  • DESK-WIDE 13 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abomasal ulcer (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Conjunctival haemorrhage

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abomasal ulcer · near15Burning sensation of… · near15Chronic hepatitis · near15Conjunctival haemorrh… · thi…15Devitalisation · near15Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Conjunctival haemorrhage

What the FDA AER plate says about Conjunctival haemorrhage

Signature read: 15 reports place Conjunctival haemorrhage in the lower third of FDA AER volume (#2295 of 2,481). Report volume is lower-third scale: 15 named reports in the openFDA extract. 3 of 15 reports were death-coded (20.0% of named reports, not a population mortality rate). Nearest volume peer: Abomasal ulcer (±0 reports). Lead species Dog (13). Lead co-reported drug Maropitant Citrate (3).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Maropitant Citrate appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 13
Cat 2

Breeds Most Affected

Chihuahua 2
Himalayan 2
Poodle (unspecified) 1
Dog (unknown) 1
Catahoula Leopard Dog 1
Terrier (unspecified) 1
Retriever - Labrador 1
Crossbred Canine/dog 1
Setter - English 1
Dog (other) 1

Associated Drugs

Maropitant Citrate 3
Carprofen 3
Pyrantel Pamoate;Sarolaner 3
Oclacitinib Maleate 2
Moxidectin 2
Buprenorphine 2
Mirtazapine 2
Water, Sodium Chloride, Sodium Lactate, Potassium Chloride, Calcium Chloride 2
Water, Sodium Chloride 2
Robenacoxib 2
Cefovecin Sodium 2
Dinotefuran, Pyriproxyfen, Permethrin 1
Gentamicin, Mometasone Furoate, And Clotrimazole 1
Levetiracetam 1
Midazolam Hydrochloride 1
Dexamethasone 1
Propofol 1
Prednisolone 1
Dexmedetomidine Hydrochloride 1
Atipamezole Hydrochloride 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Conjunctival haemorrhage (#2295 of 2,481 by report volume); death-coded 20.0%. PlainBreed reaction plate · report volume stamp 15 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →